Oppenheimer analyst Christopher Marai weighed in on Raptor Pharmaceuticals (NASDAQ: RPTP) following reports today that the company is looking to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE